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Background: The release of antibiotics into aquatic environments has made the treatment of wastewater
containing antibiotics a world-wide public health problem. The ability of microbial fuel cells (MFCs) to harvest
electricity from organic waste and renewable biomass is attracting increased interest in wastewater treatment.
In this paper we investigated the bioelectrochemical response of an electroactive mixed-culture biofilm in MFC to
different tobramycin concentrations.
Results: The electroactive biofilms showed a high degree of robustness against tobramycin at the level of μg/L.
The current generation responses of the biofilms were affected by the presence of tobramycin. The inhibition ratio
of the MFC increased exponentially with the tobramycin concentrations in the range of 0.1-1.9 g/L. The bacterial
communities of the biofilms vary with the concentrations of tobramycin, the equilibrium of which is critical for the
stability of electroactive biofilms based-MFC.
Conclusions: Experimental results demonstrate that the electroactive biofilm-based MFC is robust against
antibiotics at the level of μg/L, but sensitive to changes in antibiotic concentration at the level of g/L. These results
could provide significant information about the effects of antibiotics on the performance MFC as a waste-treatment
technology.Background
Antibiotics, one of the important group of pharmaceuti-
cals in human and veterinary medicine, are widely used
in the prevention and treatment of diseases and have
been detected in various aquatic environments, for ex-
ample, wastewater, surface water, ground water and drink-
ing water [1-3]. Therefore, the release of antibiotics to the
aquatic environment as well as its related environmental
issues and public health problems have attracted great at-
tention. Biological treatment, the use of bacteria and other
microorganisms to remove contaminants by assimilating
or oxidizing them, is still regarded as the most common
and economical approach for the treatment of contami-
nants in wastewater [4]. Traditionally aerobic treatment
consumes large amounts of electrical energy for aeration
[5]. Anaerobic treatment is generally only suitable for
high-strength wastewater streams typically produced by
industry [6].* Correspondence: wuwenguo@hqu.edu.cn
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unless otherwise stated.Microbial fuel cell (MFC) as a device capable of harvest-
ing electricity from organic waste and renewable biomass,
has attracted great interest for wastewater treatment [5].
There are various reports about MFCs for biodegradable
organics as substrates, for example, glucose, lactate,
sucrose, domestic wastewater, brewery wastewater, whey
wastewater and starch processing wastewater [7-11].
Recently MFC technology used for removing toxic and
recalcitrant contaminants as substitute substrates in waste-
water with much higher chemical oxygen demand (COD)
removal efficiencies has drawn great attention [4,12]. The
treatment capacity of MFC technology was mainly depen-
dent on the performance of the MFC. In contrast to plank-
tonic cells, wastewater-derived electroactive biofilms show
less susceptibility to toxins making MFCs promising for
application in the wastewater treatment field [13]. Further-
more, the goal of wastewater treatment is COD removal.
However, the question that is still largely unaddressed is
the effect of the toxins on the performance of electroactive
biofilms-based MFC accomplishing removal of COD in
pharmaceutical wastewater treatment.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ium Streptomyces tenebrarius, is commonly used because
of its enhanced effectiveness against infections with the
opportunistic pathogen Pseudomonas aeruginosa [14].
Tobramycin targets the decoding aminoacyl site on the
16S ribosomal RNA, induces miscoding during translation
and cell death ensues [15,16]. Herein, the impact of tobra-
mycin on the performance of electroactive biofilms-based
MFC was studied. The mixed-culture microorganism
community was harvested from wastewater and formed
electrochemically active biofilms on the anode generating
steady current. An adaptation or change of the microbial
community will influence the biofilm structure and the
stability of electroactive biofilms-based MFC [17]. Hence,
the microbial community of the anodic biofilm was ana-
lyzed using pyrosequencing and changes of the microbial
diversity with different concentrations of tobramycin
were determined by denaturing gradient gel electrophor-
esis (DGGE).
Results and discussion
Effects of tobramycin on the performance of MFCs
Electrochemically active biofilms were enriched on the
anode of MFC, whereupon a repeatable and steady out-
put current in the range of 1.2-1.4 mA was developed
at the resistance of 300Ω without antibiotic (batch 1 inFigure 1 Current response of electroactive biofilms-based MFC in the
(C), 1 mM (D), 2 mM (E) and 4 mM (F). Arrows indicate the addition of toFigure 1). Tobramycin was added into the MFC when the
current was stabilized in batch 2. There was also no
obvious immediate current decrease after addition of
tobramycin at different concentrations (batch 2). However,
subsequent batches exhibited distinct current profiles
which were more notable at increased tobramycin con-
centrations. At concentrations of 0.2, 0.5, and 1 mM, inhi-
bition was only exhibited at the beginning of the batch,
after which a stable maximum current was maintained.
Obvious inhibitions were observed in the MFC with
tobramycin concentration of 2 mM at batch 3 and the
MFC showed significant inhibition as the concentration
increased to 4 mM. However, for the MFCs with tobra-
mycin concentrations of 2 and 4 mM, current recovered 4
and 6 batches post antibiotic addition. These results sug-
gested that some microbial species in the biofilm directly
or indirectly facilitating current generation in the biofilm
could be recovered from those community members who
were not killed by the given antibiotic dose and exposure
time, reflected by the recovering stable current for a few
batches. The current recovery of MFCs indicated the
resistance of the microbial biofilms against the presence of
tobramycin in the range of 0.2-4 mM, corresponding to a
concentration range of about 0.1-1.9 g/L. Furthermore,
pharmaceuticals have been found in surface waters and
wastewaters at levels of up to a few μg/L [18]. It suggestedabsence (A) and presence of tobramycin at 0.2 mM (B), 0.5 mM
bramycin.
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treatment containing antibiotics in this range. A similar
result was also reported that no effect was observed in
biofilms-based MFCs in the presence of toxins which were
at concentrations an order of magnitude higher than aver-
age concentrations in wastewaters [13].
Inhibition ratio of MFCs correlated to tobramycin
concentrations
In order to further explore the electroactive biofilms
against antibiotics at levels of g/L, we compared the inhib-
ition ratios of electroactive biofilms-based MFCs in the
presence of different concentrations of tobramycin. As
shown in Figure 2, tobramycin showed an exponential
relationship of the inhibition ratio with the antibiotic
concentrations. The regression equation is:
y ¼ −10:3 1−e0:4x ; R2 ¼ 0:99998
This indicated that the reaction taking place on the
anode of the MFC would be a combination of biofilm
kinetics and electrochemical kinetics. The changing of
kinetic inhibition of microorganisms in the biofilm
would be one reason of the non-linear correlation be-
tween tobramycin and inhibition ratio [19]. The inhib-
ition ratio of tobramycin drastically increased from 0.2%
to 42.6% as the antibiotic concentrations were increased
from 0.2 mM to 4 mM. The tobramycin concentration
of 4 mM (1870 mg/L) is three orders of magnitude
higher than the reported minimal biofilm eliminating
concentration (MBEC) of E. coli (2 mg/L) measured by the
traditional colony-forming unit (CFU) counting method
[20]. The inhibition of the biofilm at the tobramycinFigure 2 Plot of the inhibition ratio for the electroactive
biofilms-based MFC in response to tobramycin at different
concentrations. Error bars represent relative standard deviations
(n = 3).concentration of 4 mM may lead to significantly reduced
substrate oxidation rates and subsequent decreased voltage
outputs and substrate consumption rates. Experimen-
tal results indicated that the electroactive biofilm-
based MFC was robust against antibiotics at the level
of μg/L but sensitive to changes in antibiotic concentra-
tion at the level of g/L. Kim et al. also reported similar
results and suggested a novel biomonitoring system using
MFCs for the detection of several toxins at the level of
mg/L [21].
MFCs exposure to continuously increasing concentration
of tobramycin
To test the continuous effect of tobramycin on MFCs, the
performance of the electroactive biofilms-based MFCs in
the presence of increasing concentrations of tobramycin
was observed (Figure 3). Similar with the result of the
MFCs in Figure 1, the current decreased in the batch
immediately after the injection of tobramycin and showed
greater reduction with the increase of concentration. How-
ever, after the addition of tobramycin at the concentration
of 6 mM, the significantly inhibited current still recovered
to a stable current. It was suggested that some biofilm com-
munity members died and some survived during each
batch with tobramycin, and then the community regrew in
the subsequent batches with no tobarmycin. Moreover, the
balance between competition and commensalism in the
microbial community of the biofilms in the presence of
tobramycin could be one of the reasons for the recovery
of a stable current. These results clearly showed the
effects of an intermittent shock load and the ability of
the anode community to recover from a shock load in
the presence of tobramycin. It provides significant infor-
mation about antibiotics effects on MFC as a waste-
treatment technology.Figure 3 Current response of electroactive biofilms-based MFC
in the presence of continuously increasing concentrations of
tobramycin. Arrows indicate the addition of tobramycin.
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The effects of tobramycin concentration on mature acet-
ate-fed MFC anode biofilm communities were analysed
using a combination of pyrosequencing and DGGE.
Pyrosequencing of the control community (before the
addition of tobramycin) yielded 1317 high-quality 16 s
rRNA gene reads and following taxonomic assignment
revealed the community to be primarily composed of 3
phyla, Proteobacteria (52.2%), Synergistetes (27.8%), and
Firmicutes (13.7%) (Figure 4). Geobacter spp. made up
38.9% of the community while Aminiphilus spp repre-
sented 27.8% of 16 s rRNA reads. These populations
correspond to band 4 and band 5, respectively (Figure 5).
This community structure is consistent with previous
analyses of a community maintained in the same labora-
tory [22]. Geobacter spp. are well-known for their capabil-
ity of colonizing and actively respiring anodes resulting in
significant current generation [23-25], while Aminiphilus
spp. likely play a role as the primary fermentative bacteria,
recycling peptones and amino acids into acetate and
hydrogen [26]. Fermenation-produced acetate could then
be ultilized by anode-respiring species such as Geobacter
spp. The third most common genera, Acetoanaerobium,
fits the role of a homo-acetogenic hydrogen scavenger
[27], and along with Geobacter and Aminiphilus is expec-
ted to be involved in a proposed syntrophic interactions
that leads to high power densities in MFCs [28]. Members
of the Bacteroidia class were also prominent in on the
DGGE gel (Figure 5) (bands 1/2), yet only represented
2.1% of the 16 s pyrosequencing reads with no clear
picture of the role they in the present community.
Results following antibiotic introduction show that
the microbial communities varied with the increase ofFigure 4 Core microbiome of electroactive biofilms-based MFC with ntobramycin concentration (Figure 5). As shown in Figure 5,
band 4, band 5, and band 6 disappeared at a tobramycin
concentration of 4 mM, as tobramycin, being most effective
against gram-negative bacteria, was able to reduce popula-
tions of Geobacter spp., Aminiphilus spp., and Acetoanaero-
bium spp. The presence of these members within the
community was associated with high power outputs and
following their loss at increased antibiotic concentrations
concurrent decreases in power outputs were observed
(Figure 1). The communities disturbed with high con-
centrations of tobramycin were the most diverse with
unknown bands emerging (Figure 5) (band 3 and 7).
Though some similarities can be seen between communi-
ties exposed to 3 mM and 4 mM tobramycin, such as the
emergence of band 3, other bands were only prominent in
one of the treatments (band 7). This suggests that though
tobramycin-resistant bacteria were enriched at higher con-
centrations, it is likely varying community structures will
emerge following antibiotic-disruption in contrast to the
stability of the community under acetate-fed conditions.
Conclusions
An electroactive biofilm based-MFC was developed and
the electrochemical response of different concentrations
of tobramycin on the electroactive mixed-culture biofilms
was studied along with the effect to community structure.
The electroactive biofilms showed a high degree of robust-
ness against tobramycin at the level of μg/L. The current
generated by the electrochemically active biofilm decreased
as the tobramycin concentration arrived in the range of
0.1-1.9 g/L and the inhibition ratio increased with the
increase of tobramycin concentration. The bacterial com-
munities of the biofilms varied with the concentrations ofo antibiotic addition (percent of total 16S rRNA reads).
Figure 5 PCR-DGGE analysis of 16S rDNA extracted from the
electroactive biofilms-based MFC without tobramycin (lane C)
and in the presence of tobramycin at concentrations of 0.5 mM
(lane T1), 1 mM (lane T2), 2 mM (lane T3) and 4 mM (lane T4).
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stability of electroactive biofilm based-MFCs. These results
could provide significant information about the effects of
antibiotics on the performance MFC as a waste-treatment
technology. In the future, studies on various other micro-
organisms and antibiotics like sulfadiazine, enoxacin and
bacitracin will provide more conclusive results for the
treatment of wastewater from pharmaceutical industries.
Methods
Construction of electroactive biofilms-based MFCs
A single-chamber MFC was constructed as described pre-
viously [29]. Briefly, the anode and cathode were placed in
parallel on the opposite sides of the chamber (13 mL) with
a distance of 1.7 cm. Non-wet proofed carbon cloth (type
A, E-TEK, Somerset, NJ, USA; 2 cm2) were used as the
anode without any treatment. Wet-proofed (30%) carbon
cloth (type B, ETEK, Somerset, NJ, USA; 7 cm2) was
coated with carbon/poly (tetrafluoroethylene) (PTFE)
layers on the air-facing side and platinum (0.5 mg/cm2
cathode area) with Nafion as binder on the water-facing
side, and used as the cathode.
Operation of electroactive biofilms-based MFCs
Medium used for enrichment and operation of the micro-
bial fuel cell was prepared as previously described [30]. So-
dium acetate (60 mM) was used as the carbon resource.
The medium (8 ml) in the MFC was inoculated with 5 mL
of electrochemically active mixed-culture microorganisms,
a mixture of gram-positive and gram-negative microorgan-
isms reported in our previous study [30]. The electroactivebiofilms-based MFC was monitored by a data acquisition
system (2700, Keithly, Cleveland, OH, USA), the acetate
medium solution was refreshed after each batch until a
stable power output was obtained at an external resistance
of 300Ω. When the standard deviation of maximal voltage
in the each batch after three batches was within ±5%,
2.6-78 μl of the tobramycin stock solution (1000 mM)
was added to the MFC medium to obtain final concen-
trations in the range of 0.2-6 mM for a single batch,
subsequent voltages were then recorded. The following
post-antibiotic batches were replaced with the fresh
acetate medium solution without tobramycin. Each con-
centration was run in triplicate.
Microbial community analysis
Biofilms were separated from the anodes of MFCs treated
with different antibiotic concentrations for 20 days (around
10 batches). Bacterial genomic DNA was extracted from
the biofilm samples using the DNeasy tissue Kits (Qiagen,
CA, USA) according to the manufacturer’s instructions.
The control community with no antibiotic addition
was then prepared for pyrosequencing. Primers devel-
oped to target the hyper-variable V4 region of the 16S
rRNA gene (Cole et al. [31]). The 454 adapter sequence
(5′- 3′) CCTATCCCCTGTGTGCCTTGGCAGTC the
forward primer AYTGGGYDTAAA GNG (Escherichia
coli position 563–577). The reverse primers were com-
posed of the adapter sequence followed by the reverse
primer sequence, CCGTCAATTCMTTTRAGT (E. coli
907–924). Twenty-five microliter PCR reaction volumes
were used for optimization followed by 50 μl amplification
reactions. A high-fidelity Taq polymerase (Invitrogen Plat-
inum) was used with along with MgSO4 (2.5 mM), vendor
supplied buffer, BSA (0.1 mg/ml), dNTPs (250 μM), and
primers (1 μM). An initial 3-min step at 95°C was followed
by 27 cycles of 95°C (45 s), 57°C (45 s), and 72°C (1 min)
with a final 3 min extension at 72°C. PCR products were
agarose gel purified (2% metaphor in TAE) and bands were
extracted with a QIAquick Gel Extraction Kit (Qiagen,
Valencia, CA). Gel extracted material was further purified
with a Qiagen PCR Cleanup kit and AMPure XP magnetic
beads. Quantification of purified PCR product was per-
formed using a Qubit fluorom- eter (Invitrogen, Carlsbad,
CA) and qPCR (ABI PRISM 7500 FAST Detection Sys-
tem). Following quantification, libraries were pooled into
equimolar amounts. Emulsion PCR and sequencing was
performed on a 454 GS Junior pyrosequencer (Roche,
Nutley, NJ, USA) at the Center for Genome Research
and Biocomputing (CGRB), Oregon State University using
titanium reagents and procedures consistent with proto-
cols for unidirectional amplicon sequencing.
Initial quality filtering was performed using MOTHUR,
alignment was performed using MUSCLE and subsequent
taxonomic identification done using RDP Classifier at an
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used for community analysis.
All samples were also subject to analysis through
DGGE. After nesting 16S ribosomal DNA (rDNA) by
using a pair of universal primers: 27 F (5′ -AGAGTTTG
ATCMTGGCTCAG-3′) and 1492R (5′ -GGTTACCTT
TGTTACGACTT-3′) [34]. The universal primer set 357 F-
GC (5′-GC-clamp-CCTACGGGAGGCAGCAG-3′) and
518R (5′- ATTACCGCGGCTGCTGG-3′) (Invitrogen,
Carlsbad, CA, USA) was used to amplify the V3 region of
bacteria 16 s rDNA from the extracted genomic DNA.
PCR amplification and cycling were performed in a
thermocycler (Thermo hybaid, MBS 0.2G, Thermo,
MA, USA). DGGE of the PCR products was carried
out in a DcodeTM Universal Mutation Detection System
(Bio-rad Laboratories, Hercules, CA, USA). Prominent
DGGE bands were then excised from the gel and their
products amplified using the same PCR system. Amplified
products from these bands were then submitted to CGRB
for sanger sequencing. Pyrosequencing and DGGE results
could then be correlated, allowing for a more comprehen-
sive community analysis.
Data deposition
Genomic datasets were deposited in the NCBI sequence
read archive under accession number. The genomic pro-
ject can also be accessed in NCBI under Genome Project
ID PRJNA252648. (accession, http://www.ncbi.nlm.nih.
gov/bioproject?term=PRJNA252648).
Calculation
The inhibition ratio (I) was calculated as I (%) = 100 ×
(AM1 –AM2)/ AM1, where AM1 was the maximal current
in the batch before tobramycin addition, AM2 was the
maximal current in the following batch after addition of
tobramycin.
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